Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Salobir, M. Medle, M. Spelic, M. Tercelj (Ljubljana, Slovenia). Comparability of shuttle walk test with 6-minutes walk test in pulmonary diseases with emphasis on pulmonary arterial hypertension. Eur Respir J 2013; 42: Suppl. 57, 5146

Member's Comments

No comment yet.

Related content which might interest you: Relationship between sit-to-stand test and six-minute walk test in patients with pulmonary arterial hypertension Source: International Congress 2015 – The challenge of choosing the best physical and functional assessment methods Year: 2015 Prognostic significance of 6-minute walk test in non-group 1 pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Prognostic impact of oxygen saturation during the 6-minute walk test in pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension Source: Eur Respir J 2012; 40: 1410-1419 Year: 2012 Physiological response to the six-minute walk test in pulmonary arterial hypertension Source: Eur Respir J 2005; 26: 667-672 Year: 2005 Six-minute walk test correlates with hemodynamic severity in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 111s Year: 2004 Clinical predictors of pulmonary hypertension in sarcoidosis Source: Eur Respir J 2008; 32: 296-302 Year: 2008 Exercise capacity in chronic obstructive pulmonary disease: Cardiopulmonary exercise testing versus 6-minute walk test Source: International Congress 2019 – Clinical implications of COPD management Year: 2019 Blood pressure variability during the 6-minute walk test in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Stops and its correlation with new measurements during the six-minute walk test in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Clinical exercise physiology in health and disease Year: 2016 Exercise testing in pulmonary arterial hypertension and in chronic heart failure Source: Eur Respir J 2004; 23: 747-751 Year: 2004 Is 6-minute walk distance (6MWD) associated with long-term outcomes in pulmonary arterial hypertension (PAH)? Results from SERAPHIN Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 564-569 Year: 2002 Exercise testing in pulmonary hypertension Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Exercise testing in pulmonary hypertension Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Exercise testing in pulmonary hypertension Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Exercise testing in pulmonary hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Exercise testing in pulmonary hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 The six-minute walking test accompanied by pulse oximetry and ventilation assessment in patients with pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013